Investors

Angel Investors

Common advice given to angel investors is to strongly recommend investing in at least 20–25 companies over a five-year period. This rule has come about because of established failure rates. What if the failure rate in biotech could be cut in half with proper AI Bio Due Diligence?

Venture Funds

Biotech venture investing has many “successful failures” – with that adjective providing an essential distinction.

Yes, investors lost all of the invested capital, and that hurt. But it was “successful” because they stayed disciplined to the investment thesis and focused on revealing the scientific truth.

In the end, the team determined the probability of making a new medicine on this mechanism was now too remote, and so the fund closed the book on the final chapter of a well-executed story.

Would a happier ending using AI machine learning to find the “scientific truth” before the invested capital is spend become a better story?